Reference
Zeidler C, et al. Tofacitinib, a novel JAK3 inhibitor, as a potential cause of distal symmetric polyneuropathy. Journal of the European Academy of Dermatology and Venereology 30: 1066-1067, No. 6, Jan 2016. Available from: URL: http://doi.org/10.1111/jdv.13114 - Germany
Rights and permissions
About this article
Cite this article
Tofacitinib. Reactions Weekly 1622, 193 (2016). https://doi.org/10.1007/s40278-016-22001-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-22001-2